Intestinal Microbiome In Polyarticular Juvenile Idiopathic Arthritis : A PILOT Study

P Müller(Leiden University Medical Center), R. ten Cate(Leiden University), T.G.J. de Meij, J. Merlijn van den Berg(Boston Children's Hospital), M L Westedt, Marion A. J. van Rossum(Reade), Daniëlle M.C. Brinkman, Lisette W. A. van Suijlekom‐Smit(Erasmus MC - Sophia Children’s Hospital), C.F. Allaart(Leiden University), TW Kuijpers(Sanquin), Andries E. Budding

Data Archiving and Networked Services (DANS)

October 31, 2013

Cited by 2

Related Papers

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series

|Arthritis & Rheumatism|2010|465

Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect

|The Lancet|1993|361

Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation

|Blood|1991|359

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

|Annals of the Rheumatic Diseases|2008|220

Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study

|Arthritis & Rheumatism|1998|217